Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 1/2015

Inhalt (22 Artikel)

Original Article – Cancer Research

CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expression

Hung-Chih Hsu, Yi-Shiuan Liu, Kai-Chi Tseng, Tsai-Sheng Yang, Chien-Yuh Yeh, Jeng-Fu You, Hsin-Yuan Hung, Shu-Jen Chen, Hua-Chien Chen

Original Article – Cancer Research

Keeping those telomeres short! an innovative intratumoral long-term drug delivery system

B. H. Laster, C. Isaacson, E. Perets, M. Msamra, E. Priel, J. Kalef-Ezra, J. Kost

Original Article – Cancer Research

Genetic variation in microRNA-binding site and prognosis of patients with colorectal cancer

Jong Gwang Kim, Yee Soo Chae, Soo Jung Lee, Byung Woog Kang, Jae Yong Park, Eun-Jin Lee, Hyo-Sung Jeon, Jun Seok Park, Gyu Seog Choi

Original Article – Cancer Research

Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer

M. Teresa Agulló-Ortuño, C. Vanesa Díaz-García, Alba Agudo-López, Carlos Pérez, Ana Cortijo, Luis Paz-Ares, Fernando López-Ríos, Francisco Pozo, Javier de Castro, Hernán Cortés-Funes, José A. López Martín

Original Article – Cancer Research

Discontinuation and non-adherence to endocrine therapy in breast cancer patients: is lack of communication the decisive factor?

P. Wuensch, A. Hahne, R. Haidinger, K. Meißler, B. Tenter, C. Stoll, B. Senf, J. Huebner

Open Access Original Article – Cancer Research

The efficacy of EGFR gene mutation testing in various samples from non-small cell lung cancer patients: a multicenter retrospective study

Paweł Krawczyk, Rodryg Ramlau, Joanna Chorostowska-Wynimko, Tomasz Powrózek, Marzena Anna Lewandowska, Janusz Limon, Bartosz Wasąg, Juliusz Pankowski, Jerzy Kozielski, Ewa Kalinka-Warzocha, Aleksandra Szczęsna, Kamila Wojas-Krawczyk, Michał Skroński, Rafał Dziadziuszko, Paulina Jaguś, Ewelina Antoszewska, Justyna Szumiło, Bożena Jarosz, Aldona Woźniak, Wojciech Jóźwicki, Wojciech Dyszkiewicz, Monika Pasieka-Lis, Dariusz M. Kowalski, Maciej Krzakowski, Jacek Jassem, Janusz Milanowski

Original Article – Cancer Research

Vascular endothelial growth factor (VEGF) polymorphism and increased risk of epithelial ovarian cancer

José Augusto Rinck-Junior, Cristiane Oliveira, Gustavo Jacob Lourenço, Regina Aparecida Martinho Sagarra, Sophie Françoise Mauricette Derchain, José Getulio Segalla, Carmen Silvia Passos Lima

Original Article – Cancer Research

Enhanced antitumor efficacy of a novel oncolytic adenovirus combined with temozolomide in the treatment of melanoma in vivo

Guan Jiang, Chao Sun, Rong-Hua Li, Zhi-Ping Wei, Jun-Nian Zheng, Yan-Qun Liu

Original Article – Cancer Research

Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancer

Mitra Tewes, Sabine Kasimir-Bauer, Anja Welt, Martin Schuler, Rainer Kimmig, Bahriye Aktas

Original Article – Cancer Research

Associations between body mass and papillary thyroid cancer stage and tumor size: a population-based study

Peter Dieringer, Evan M. Klass, Brenna Caine, Julie Smith-Gagen

Open Access Review – Clinical Oncology

Paraneoplastic neurological syndromes associated with ovarian tumors

Mikolaj Piotr Zaborowski, Marek Spaczynski, Ewa Nowak-Markwitz, Slawomir Michalak

Original Article – Clinical Oncology

Epirubicin combined with oxaliplatin and 5-day continuous infusion of 5-fluorouracil as a first-line treatment for metastatic gastric cancer: treatment outcomes and analysis of prognostic factors

Xiaodong Zhu, Xiaoying Zhao, Wei Peng, Si Sun, Jun Cao, Dongmei Ji, Xin Liu, Chenchen Wang, Mingzu Huang, Hui Yu, Weijian Guo, Jin Li, Jiliang Yin

Original Article – Clinical Oncology

Predictive and prognostic value of circulating endothelial cells in non-small cell lung cancer patients treated with standard chemotherapy

Fadi Najjar, Moosheer Alammar, Marroan Bachour, Nissreen Almalla, Moaz Altahan, Ali Alali, Ghassan Al-Massarani

Open Access Original Article – Clinical Oncology

Paclitaxel, ifosfamide, and cisplatin (TIP) as salvage and consolidation chemotherapy for advanced germ cell tumor

Masahiro Kurobe, Koji Kawai, Takehiro Oikawa, Daishi Ichioka, Shuya Kandori, Ei-ichirou Takaoka, Takahiro Kojima, Akira Joraku, Takahiro Suetomi, Jun Miyazaki, Hiroyuki Nishiyama

Original Article – Clinical Oncology

Dynamics of fertility impairment and recovery after allogeneic haematopoietic stem cell transplantation in childhood and adolescence: results from a longitudinal study

C. Pfitzer, H. Orawa, M. Balcerek, T. Langer, U. Dirksen, P. Keslova, N. Zubarovskaya, F. R. Schuster, A. Jarisch, G. Strauss, A. Borgmann-Staudt

Original Article – Clinical Oncology

Can lymph node evaluation be performed well by video-assisted thoracic surgery?

Zhenrong Zhang, Hongxiang Feng, Xiaowei Wang, Chaoyang Liang, Deruo Liu

Original Article – Clinical Oncology

A phase 3 non-inferiority study of 5-FU/l-leucovorin/irinotecan (FOLFIRI) versus irinotecan/S-1 (IRIS) as second-line chemotherapy for metastatic colorectal cancer: updated results of the FIRIS study

Hirofumi Yasui, Kei Muro, Yasuhiro Shimada, Akihito Tsuji, Shinichi Sameshima, Hideo Baba, Taroh Satoh, Tadamichi Denda, Kenji Ina, Tomohiro Nishina, Kensei Yamaguchi, Taito Esaki, Shinya Tokunaga, Hiroyuki Kuwano, Narikazu Boku, Yoshito Komatsu, Masahiko Watanabe, Ichinosuke Hyodo, Satoshi Morita, Kenichi Sugihara

Original Article – Clinical Oncology

Selection of adjuvant intravesical therapies using the European Organization for Research and Treatment of Cancer scoring system in patients at intermediate risk of non-muscle-invasive bladder cancer

Mitsuo Ofude, Yasuhide Kitagawa, Hiroshi Yaegashi, Kouji Izumi, Satoru Ueno, Yoshifumi Kadono, Hiroyuki Konaka, Atsushi Mizokami, Mikio Namiki

Original Article – Clinical Oncology

Adjuvant chemotherapy after radical cystectomy for bladder cancer: a comparative study using inverse-probability-of-treatment weighting

Taekmin Kwon, In Gab Jeong, JungBok Lee, Chunwoo Lee, Dalsan You, Bumsik Hong, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim

Original Article – Clinical Oncology

Severe gastrointestinal bleeding in patients with locally advanced head and neck squamous cell carcinoma treated by concurrent radiotherapy and Cetuximab

Naoya Murakami, Seiichi Yoshimoto, Fumihiko Matsumoto, Takao Ueno, Yoshinori Ito, Satoru Watanabe, Kazuma Kobayashi, Ken Harada, Mayuka Kitaguchi, Shuhei Sekii, Kana Takahashi, Kotaro Yoshio, Koji Inaba, Madoka Morota, Minako Sumi, Yutaka Saito, Jun Itami

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.